mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin has been researched along with wr 1065 in 1 studies
Studies (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Trials (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Recent Studies (post-2010) (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Studies (wr 1065) | Trials (wr 1065) | Recent Studies (post-2010) (wr 1065) |
---|---|---|---|---|---|
69 | 0 | 42 | 227 | 6 | 22 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crowe, ME; Levin, LA; Lieven, CJ; Sheibani, N; Thompson, AF | 1 |
1 other study(ies) available for mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and wr 1065
Article | Year |
---|---|
Borane-protected phosphines are redox-active radioprotective agents for endothelial cells.
Topics: Animals; Aorta; Boranes; Cattle; Cells, Cultured; Clone Cells; Endothelial Cells; Gamma Rays; Humans; Mercaptoethylamines; Metalloporphyrins; Oxidation-Reduction; Phosphines; Polyethylene Glycols; Radiation-Protective Agents; Signal Transduction; Superoxide Dismutase; Superoxides | 2015 |